Trium Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-109,482
Closed -$2.95M 95
2022
Q4
$2.95M Buy
+109,482
New +$2.88M 1.09% 35

Other funds holding MYOV

Trium Capital's MYOV Position: Q1 2023 in Review

Trium Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 109,482 shares — an estimated $2.95M sold.

Trium Capital first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $2.95M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Trium Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Trium Capital sold 109,482 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.95M.
  • Trium Capital first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
  • Trium Capital's Myovant Sciences Ltd. position peaked at $2.95M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Trium Capital's 13F filing for Q1 2023, filed 16 May 2023.